Improvement of Spontaneous Locomotor Activity in a Murine Model of Duchenne Muscular Dystrophy by N-Acetylglucosamine Alone and in Combination With Prednisolone.

In this analysis, co‐treatment with GlcNAc at 2.4 and 4.8 mg/mL resulted in a highly significant increase in activity compared to prednisolone alone ( p < 0.0001), while the 9.6 mg/mL dose also conferred a significant, albeit more modest, increase ( p < 0.05) (Figure S5 ).

also in 132,142 other papers